Numeta Ped G19% E, Infusionslösung zur totalen parenteralen Ernährung
7680614250027
CH-61425
Infusionslösung zur totalen parenteralen Ernährung
Associated product:
NUMETA PED G19% E sol perf 6 x 1000 ml
1 / 3
google
Article details
- Package size
- 6 x 1000
- Selling units
- 6
- Measure
- ml
- Galenic form
- Infusionslösung zur totalen parenteralen Ernährung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
III
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
191.5 G | Substance | Wirkstoff (Principe actif) |
|
III
|
28.1 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
1.83 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.92 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.37 G | Substance | Wirkstoff (Principe actif) |
|
II
|
431.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
2.29 G | Substance | Wirkstoff (Principe actif) |
|
II
|
913.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
866.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.53 G | Substance | Wirkstoff (Principe actif) |
|
II
|
2.29 G | Substance | Wirkstoff (Principe actif) |
|
II
|
2.51 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
549.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
568.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
960.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
686.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
913.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
137.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
847.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
459.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
176.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.74 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.79 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.14 G | Substance | Wirkstoff (Principe actif) |
|
II
|
564.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
549.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
2.21 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
4.5 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
30.0 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
247.0 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
58.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
41.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
3.3 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
5.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
9.3 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
48.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
11.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
55.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.5 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
23.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
191.5 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
28.1 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
46.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
32.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
2.6 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.8 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
9.4 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
37.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
8.8 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
43.0 MMOLL | Substance | Wirkstoff (Principe actif) |
Authorization holder
Baxter AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61425
- Drug name
- Numeta Ped, Infusionslösung zur totalen parenteralen Ernährung
- Galenic form
- EMUP
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/01/2012
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.01.2.
- Domain
- Human medicine
Package details
- Description (FR)
- NUMETA PED G19% E sol perf 6 x 1000 ml
- Description (DE)
- NUMETA PED G19% E Inf Lös 6 x 1000 ml
- Market launch
- 18/01/2012
- Narcotic (BTM)
- No
Other package sizes (1)
NUMETA PED G16% E sol perf 6 sach 500 ml
6 x 500 ML
GTIN: 7680614250010